B3GAT3
Basic information
Region (hg38): 11:62615296-62622154
Links
Phenotypes
GenCC
Source:
- Larsen-like syndrome, B3GAT3 type (Limited), mode of inheritance: AR
- Larsen-like syndrome, B3GAT3 type (Strong), mode of inheritance: AR
- Larsen-like syndrome, B3GAT3 type (Moderate), mode of inheritance: AR
- Larsen-like syndrome, B3GAT3 type (Strong), mode of inheritance: AR
- Larsen-like syndrome, B3GAT3 type (Supportive), mode of inheritance: AR
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects | AR | General | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Musculoskeletal | 21763480; 24668659 |
ClinVar
This is a list of variants' phenotypes submitted to
- Larsen-like_syndrome,_B3GAT3_type (220 variants)
- not_provided (66 variants)
- Inborn_genetic_diseases (53 variants)
- B3GAT3-related_disorder (6 variants)
- not_specified (4 variants)
- MULTIPLE_JOINT_DISLOCATIONS,_SHORT_STATURE,_AND_CRANIOFACIAL_DYSMORPHISM_WITHOUT_CONGENITAL_HEART_DEFECTS (3 variants)
- MULTIPLE_JOINT_DISLOCATIONS,_SHORT_STATURE,_AND_CRANIOFACIAL_DYSMORPHISM_WITH_CONGENITAL_HEART_DEFECTS (2 variants)
- Multiple_joint_dislocations,_short_stature,_craniofacial_dysmorphism,_with_or_without_congenital_heart_defects (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the B3GAT3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012200.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 64 | 66 | ||||
missense | 118 | 134 | ||||
nonsense | 11 | |||||
start loss | 4 | 4 | ||||
frameshift | 8 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 15 | 18 | 122 | 69 | 1 |
Highest pathogenic variant AF is 0.0000756514
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
B3GAT3 | protein_coding | protein_coding | ENST00000265471 | 5 | 6880 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.71e-8 | 0.299 | 125715 | 0 | 30 | 125745 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.692 | 178 | 206 | 0.864 | 0.0000136 | 2087 |
Missense in Polyphen | 47 | 54.975 | 0.85493 | 604 | ||
Synonymous | -0.226 | 93 | 90.3 | 1.03 | 0.00000514 | 768 |
Loss of Function | 0.592 | 13 | 15.5 | 0.838 | 9.39e-7 | 139 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000117 | 0.000117 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000152 | 0.000149 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000164 | 0.000163 |
Other | 0.000331 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosaminoglycans biosynthesis (PubMed:25893793). Involved in forming the linkage tetrasaccharide present in heparan sulfate and chondroitin sulfate. Transfers a glucuronic acid moiety from the uridine diphosphate-glucuronic acid (UDP-GlcUA) to the common linkage region trisaccharide Gal-beta-1,3-Gal-beta-1,4- Xyl covalently bound to a Ser residue at the glycosaminylglycan attachment site of proteoglycans. Can also play a role in the biosynthesis of l2/HNK-1 carbohydrate epitope on glycoproteins. Shows strict specificity for Gal-beta-1,3-Gal-beta-1,4-Xyl, exhibiting negligible incorporation into other galactoside substrates including Galbeta1-3Gal beta1-O-benzyl, Galbeta1- 4GlcNAc and Galbeta1-4Glc. Stimulates 2-phosphoxylose phosphatase activity of PXYLP1 in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA) during completion of linkage region formation (PubMed:24425863). {ECO:0000269|PubMed:24425863, ECO:0000269|PubMed:25893793}.;
- Disease
- DISEASE: Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects (JDSCD) [MIM:245600]: An autosomal recessive disease characterized by dysmorphic facies, bilateral dislocations of the elbows, hips, and knees, clubfeet, and short stature, as well as cardiovascular defects. {ECO:0000269|PubMed:21763480, ECO:0000269|PubMed:24668659, ECO:0000269|PubMed:25893793, ECO:0000269|PubMed:26086840}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human);Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Proteoglycan biosynthesis;glycoaminoglycan-protein linkage region biosynthesis;chondroitin sulfate biosynthesis;heparan sulfate biosynthesis;dermatan sulfate biosynthesis;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.600
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 38.82
Haploinsufficiency Scores
- pHI
- 0.248
- hipred
- N
- hipred_score
- 0.291
- ghis
- 0.567
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.434
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- B3gat3
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- b3gat3
- Affected structure
- pharyngeal arch 3-7
- Phenotype tag
- abnormal
- Phenotype quality
- shape
Gene ontology
- Biological process
- glycosaminoglycan biosynthetic process;protein glycosylation;heparan sulfate proteoglycan biosynthetic process;glycosaminoglycan metabolic process;positive regulation of catalytic activity;regulation of phosphoprotein phosphatase activity;chondroitin sulfate proteoglycan biosynthetic process;dermatan sulfate proteoglycan biosynthetic process;positive regulation of intracellular protein transport
- Cellular component
- Golgi membrane;Golgi apparatus;cis-Golgi network;membrane;integral component of membrane;extracellular exosome
- Molecular function
- protein binding;galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity;glucuronosyltransferase activity;metal ion binding;protein phosphatase activator activity